DynaCirc CR Side Effects
Generic name: isradipine
Note: This document contains side effect information about isradipine. Some of the dosage forms listed on this page may not apply to the brand name DynaCirc CR.
Some side effects of DynaCirc CR may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to isradipine: oral capsule, oral tablet, oral tablet extended release
Along with its needed effects, isradipine (the active ingredient contained in DynaCirc CR) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking isradipine:More common
- Bloating or swelling of face, arms, hands, lower legs, or feet
- tingling of hands or feet
- unusual weight gain or loss
- Chest pain
- difficult or labored breathing
- fast, irregular, pounding, or racing heartbeat or pulse
- feeling of warmth
- full or bloated feeling
- pressure in the stomach
- redness of the face, neck, arms and occasionally, upper chest
- shortness of breath
- swelling of abdominal or stomach area
- tightness in chest
- unusual tiredness or weakness
Get emergency help immediately if any of the following symptoms of overdose occur while taking isradipine:Symptoms of Overdose
- Blurred vision
- dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly
Some side effects of isradipine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- difficulty having a bowel movement (stool)
- stomach soreness or discomfort
For Healthcare Professionals
Applies to isradipine: oral capsule, oral tablet extended release
Isradipine (the active ingredient contained in DynaCirc CR) is generally well-tolerated. Most side effects occurred as commonly as with placebo in placebo-controlled trials, except for flushing, headache, and palpitations.
Cardiovascular side effects are among the most common, and are related to the vasodilatory properties of isradipine (the active ingredient contained in DynaCirc CR) Peripheral edema and flushing are reported in 3% to 14% of patients, being more common at higher doses. Dizziness occurs in 3% to 8% of patients.
Palpitations or a greater awareness of heart beats is reported in 1% to 5% of patients. Flushing and palpitations are more likely with dosages greater than 5 mg daily; women have reported flushing more than men. Edema was reported in up to 22% of patients in one study (mean dose was 5.9 mg TID). In large studies, the incidence of edema is less than 3%, and appeared to be more likely in patients greater than 60 years of age.
Isradipine does not appear to adversely affect plasma lipids.
Headache was reported in up to 16% of patients in one study, although the mean dose was 5.9 mg three times daily to treat angina pectoris. Headache is more likely with dosages greater than 5 mg daily. Visual disturbances are reported in less than 2% of patients. Sleep disturbances are reported in 0.1% of patients.
Nervous system side effects are probably related to the vasodilatory effects of isradipine. Headache is reported in 9% to 30% of patients and fatigue is reported in 7% of patients.
Anorexia, nausea, vomiting, and diarrhea are reported in less than 4% of patients.
Gastrointestinal side effects are unusual, and include constipation in less than 2% of patients.
Respiratory system complaints include dyspnea and cough in 2% of patients.
Musculoskeletal pain is reported in 1% of patients.
Dermatologic complaints of "disturbed skin sensation" are reported in less than 4% of patients.
Hypersensitivity reactions to isradipine (the active ingredient contained in DynaCirc CR) are rare. Pruritus, urticaria, and angioedema have been reported.
More DynaCirc CR resources
- DynaCirc CR Prescribing Information (FDA)
- DynaCirc CR extended-release tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Isradipine Professional Patient Advice (Wolters Kluwer)
- Isradipine Monograph (AHFS DI)
- Isradipine Prescribing Information (FDA)
- isradipine MedFacts Consumer Leaflet (Wolters Kluwer)
- DynaCirc Prescribing Information (FDA)
- Dynacirc CR Concise Consumer Information (Cerner Multum)
- Dynacirc CR Advanced Consumer (Micromedex) - Includes Dosage Information
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.